Biotechnology
GEN inCode Announces Completion of £3M Institutional Foundation Fundraise
OXFORD, England, Sept. 1, 2020 /PRNewswire/ -- GEN inCode UK Limited, the privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease, announces today the completion of a £3.0M institutional fundraise to internationally scale its prod...
2020-09-01 14:00
2074
GenScript Biotech Corporation signs exclusive agreement with PH biotech firm to distribute faster, more accurate and more affordable immunity tests for COVID-19
SINGAPORE, Sept. 1, 2020 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK) entered an exclusive partnership with Philippines biotech company, IP Biotech. ). This will allow the firm to distribute a breakthrough test kit designed to measure the levels of neutralizing...
2020-09-01 10:30
9966
Cedrus Group's Chairman Mr. Rani Jarkas Invited to Speak at the ANNUAL BIOPHARMA DEVELOPMENT AND PRODUCTION WEEK
HONG KONG, Sept. 1, 2020 /PRNewswire/ -- The Chairman of Cedrus Group ("Cedrus")
2020-09-01 09:00
4445
Viva Biotech Announced 2020 Interim Results
Financial Highlights for the 6 months ended June 30, 2020 * Revenue amounted to RMB197.6 million, representing a YOY increase of 38.9% * Gross profit amounted to RMB100.1 million, representing a YOY increase of 39.2%, with Gross profit margin of 50.7% * Adjusted net profit rose to RMB123.7 m...
2020-08-31 23:27
6723
GenScript Reports 2020 Interim Results and Provides Business Update
NANJING, China, Aug. 31, 2020 /PRNewswire/ -- GenScript Biotech Corp. (Stock Code: 1548.HK), a leading global biotechnology company, today reported interim results for the six months endedJune 30, 2020 and provided a corporate update. Revenue of the Group for the six months endedJune 30, 2020 was...
2020-08-31 11:32
11558
Innovent Announces the Results of the Phase 1/2 Clinical Study of PCSK9 Antibody Tafolecimab at the European Society of Cardiology Annual Conference
SAN FRANCISCO and SUZHOU, China, Aug. 31, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune a...
2020-08-31 08:00
5351
G-ray Switzerland announces new CEO, closes successful funding round
NEUCHÂTEL, Switzerland, Aug. 31, 2020 /PRNewswire/ -- G-ray Switzerland, the medical imaging and industrial diagnosis start-up founded in 2014, has announced the appointment of Luis Pallares as Chief Executive Officer, as the company embarks on an accelerated growth drive and completes a successf...
2020-08-31 06:00
3439
Million-selling Erba COVID-19 antibody tests now validated on leading ELISA analysers
LONDON, Aug. 31, 2020 /PRNewswire/ -- To improve global availability of high-quality testing methods for SARS-CoV-2,Erba Mannheim announced the availability of validated automated protocols for their successful range of ErbaLisa COVID-19 IgG and IgM ELISA kits. Optimised protocols for popular ins...
2020-08-31 06:00
3118
Changsha Haike, a HYCOR Biomedical Partner, Announces Registration From China HMPA for the ALLEOS™ 2000 System
GARDEN GROVE, California, Aug. 29, 2020 /PRNewswire/ -- HYCOR Biomedical, a leading manufacturer ofin vitro diagnostic products for allergy testing, and Changsha Haike Biotechnology Co., Ltd., its Chinese manufacturing partner, announced registration from Hunan Medical Products Administration ...
2020-08-29 05:03
5727
Sirtex Medical and China Grand Pharmaceutical announce landmark drug registration milestone
Approval issued to file new drug application for SIR-Spheres® Y-90 resin microspheres inChina based on existing clinical trial data. WOBURN, Mass., Aug. 27, 2020 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced today that Sirtex and ...
2020-08-27 20:30
3511
Enrolment initiated in World's First RCT with Sirolimus Coated Balloon for the treatment of Below-the-Knee (BTK) Peripheral Artery Disease
SINGAPORE, Aug. 27, 2020 /PRNewswire/ -- Concept Medical Inc
2020-08-27 18:16
3918
Ascentage Pharma Releases Preclinical Results of IAP Antagonist APG-1387 in an Oral Presentation at EASL ILC 2020
SUZHOU, China and ROCKVILLE, Md., Aug. 27, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that preclinical study resul...
2020-08-27 18:10
4538
How the Dutch resume elective surgery in melanoma after COVID delays
ROTTERDAM, Netherlands and SAN DIEGO, Aug. 26, 2020 /PRNewswire/ -- SkylineDx signed a collaboration agreement with a multi-disciplinary clinical consortium inthe Netherlands that designed a trial to implement a diagnostic innovation to manage continuity of care delivery when resources are under ...
2020-08-26 21:06
2880
DiscGenics Raises $50 Million in Series C Funding
SALT LAKE CITY, Aug. 26, 2020 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced it has raised$50 million in a Serie...
2020-08-26 08:30
2991
AGC Biologics Completes PPQ Manufacturing Campaign with Provention Bio for Type 1 Diabetes Product Candidate, Teplizumab
SEATTLE, Aug. 25, 2020 /PRNewswire/ -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), achieved the on-schedule completion of a drug substance Process Performance Qualification (PPQ) campaign, focused on teplizumab (PRV-031) for partn...
2020-08-25 22:00
5164
FDA Accepts Filing of New Drug Application for Tepotinib for the Treatment of Patients with Metastatic NSCLC with METex14 Skipping Alterations
- Tepotinib granted Priority Review and is being evaluated under FDA Real-Time Oncology Review (RTOR) pilot program - Tepotinib is a highly targeted inhibitor of c-MET that is administered as a once-daily oral tablet - Data show robust, consistent and durable clinical response across different ...
2020-08-25 21:22
2583
Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2021
HONG KONG, Aug. 25, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for...
2020-08-25 04:16
18635
One Drop Announces Nearly $100M Financing And Commitments By Bayer
$98.7M financing, development fees and commercial milestone commitments accelerate the development and commercialization of One Drop's digital health platform and data-driven predictive capabilities across multiple therapeutic areas NEW YORK, Aug. 24, 2020 /PRNewswire/ -- One Drop, a leader in d...
2020-08-24 19:00
3999
Singapore's Restalyst develops highly sensitive COVID-19 antibody test comparable to market leaders
SINGAPORE, Aug. 24, 2020 /PRNewswire/ -- Singapore biomedical firm Restalyst has developed a COVID-19 antibody test, COVID19N-REAAD™, which will be instrumental in establishing disease prevalence in populations and the exposure risk factors associated with infection. This will enable healthcare a...
2020-08-24 12:42
2335
US FDA Awards Orphan Drug Designation (ODD) To Paxalisib For Malignant Glioma, Including DIPG
SYDNEY, Aug. 24, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Kazia's paxalisib (formerl...
2020-08-24 09:14
6352
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Multiple achievements made in China-Hungary BRI conference
[Picked up by 309 media titles]
2024-05-03 06:59
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 293 media titles]
2024-04-30 10:11
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 280 media titles]
2024-05-03 06:25Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Most Read
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
2024-04-30 10:11
2999
Ferretti's Dazzling Presence at the 2024 Singapore Yachting Festival: Showcasing Evolving Trends in Luxury Yachting
2024-04-28 15:02
2966
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2965
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
2024-04-28 09:39
2848